Developments in lung SABR

Author(s): Caroline Maguire, Kyle Woods, Dr Crispin Hiley

Hospital: University College London Hospital; GenesisCare

Reference: RAD Magazine, 49, 583, 13-14


The use of stereotactic ablative radiotherapy (SABR) has expanded in the UK over the past decade. In 2008, the UK SABR Consortium was established to help achieve a consensus in implementing and developing SABR in a safe and managed way. In 2011, the National Radiotherapy Implementation Group (NRIG) report recommended that SABR had become standard of care for the management of medically inoperable early stage non-small cell lung cancer patients (ES-NSCLC).

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more